Michael P Frogel
Affiliation: Long Island Jewish Medical Center
- Prevention of hospitalization due to respiratory syncytial virus: results from the Palivizumab Outcomes RegistryM Frogel
Division of General Pediatrics, Schneider Children s Hospital, New Hyde Park, NY 11042, USA
J Perinatol 28:511-7. 2008..The Palivizumab Outcomes Registry contains data on infants and young children who received palivizumab for the prevention of respiratory syncytial virus (RSV) that causes serious lower respiratory tract illness...
- Improved outcomes with home-based administration of palivizumab: results from the 2000-2004 Palivizumab Outcomes RegistryMichael Frogel
Schneider Children s Hospital, New Hyde Park, NY 11042, USA
Pediatr Infect Dis J 27:870-3. 2008....
- A systematic review of compliance with palivizumab administration for RSV immunoprophylaxisMichael P Frogel
Schneider Children s Hospital, Division of General Pediatrics, 410 Lakeville Rd, New Hyde Park, NY 11042, USA
J Manag Care Pharm 16:46-58. 2010..It is unclear if compliance with monthly doses is a problem and whether noncompliance increases the risk of RSV hospitalizations in routine clinical practice...
- Palivizumab prophylaxis of respiratory syncytial virus disease in 2000-2001: results from The Palivizumab Outcomes RegistryCurt Parnes
Pediatr Pulmonol 35:484-9. 2003..The Palivizumab Outcomes Registry provides an opportunity to assess palivizumab utilization and clinical effectiveness in the US...